RESEARCH PAPER
Is the advancement of diabetic angiopathy evaluated as ankle-brachial index directly associated with current glycaemic control?
 
More details
Hide details
1
Diabetology Department, Institute of Rural Health, Lublin, Poland
2
Institute of Public Health, Pope John Paul II State School of Higher Education in Biała Podlaska, Poland
3
Department of Functional Research, Institute of Rural Health, Lublin, Poland
4
Department of Hypertension and Diabetology, Medical University, Gdańsk, Poland
 
Ann Agric Environ Med 2012;19(3):563–566
KEYWORDS:
ABSTRACT:
Introduction and objective:
Diabetic patients are at high risk for peripheral arterial disease (PAD) characterized by symptoms of intermittent claudication or critical limb ischemia. Measurement of ankle-brachial index (ABI) has emerged as the diagnostic tool of choice, because it is relatively simple, non-invasive and inexpensive. It is also an independent marker of increased morbidity and mortality from cardiovascular diseases. The aim of the presented study was to assess the relationship between current glycemic control defined by glycated hemoglobin (HbA1c) level, and quantitative changes in the arteries of the lower limbs in patients with type 2 diabetes.

Material and Methods:
175 patients with type 2 diabetes hospitalized in the Diabetology Ward were studied. VENO Doppler and a sphygmomanometer were used to assess blood flow.

Results:
The average level of HbA1c was assessed at 8.48%. Although the average level of ABI indicator was 1.20 (normal), only 45% of evaluated patients had their individual index within the normal range. Signs of ischemia were found in 17.7% of examined subjects. There was no conclusive correlation between ABI and HbA1c levels.

Conclusions:
The current level of glycemic control evaluated as HbA1c has no direct impact on the advancement of diabetic angiopathy evaluated as ABI.

CORRESPONDING AUTHOR:
Piotr Dziemidok   
Diabetology Department, Institute of Rural Health, Lublin, Poland
 
REFERENCES (28):
1. Hinchliffe RJ, Andros G, Apelqvist J, Bakker K, Fiedrichs S, Lammer J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev. 2012; 28 (Suppl. 1): 179-217.
2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990; 13(5): 513-521.
3. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on between individuals with and without peripheral vascular disease. The EURODIAL study. Diabetologia. 2008; 51(5): 747-755.
4. Schaper NC. Lessons from Eurodiale. Diabetes Metab Res Rev. 2012; 28 (Suppl. 1): 21-26.
5. Apelqvist J, Bakker K, van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007). Diabetes Metab Res Rev. 2008; 24 (Suppl. 1): 181-187.
6. Xu D, Li J, Zou L, Xu Y, Hu D, Pagodo SL, Ma Y. Sensitivity and specificity of the ankle–brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010; 15(5): 361-369.
7. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6): 738-743.
8. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality. The Strong Heart Study. Circulation. 2004; 109(6): 733-739.
9. Norman P E, Davis W A, Bruce D G, Davis T M E. Peripheral arterial disease and risk of cardiac death in type 2 diabetes. The Fremantle Diabetes Study. Diabetes Care. 2006; 29(3): 575-580.
10. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352(9131): 837-853.
11. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129-139.
12. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. The Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545-2559.
13. Charuruks N, Milintagas A, Watanaboonyoungcharoen P, Ariyaboonsiri C. Determination of reference intervals of HbA1C (DCCT/NGSP) and HbA1C (IFCC) in adults. J Med Assoc Thai. 2005; 88(6): 810-816.
14. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004; 27(7): 1591-1597.
15. Schaper NC, Andros G, Apelqvist J, Bakker K, Lammer J, Lepantalo M, et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2012; 28 (Suppl.1): 218-224.
16. Reaven PD, Sacks J. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia. 2005; 48(2): 379-385.
17. Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care. 2005; 28(9): 2206-2210.
18. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991; 87(2-3): 119-128.
19. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Rouckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996; 313(7070): 1440-1444.
20. American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26(12): 3333-3341.
21. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Eur J Vasc Endovasc Surg. 2005; 29(2): 182-189.
22. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose. The Tanno and Sobetsu Study. Diabetes Care. 2003; 26(2): 437-440.
23. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002; 25(5): 894-899.
24. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995; 38(1): 86-96.
25. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med. 1992; 9(8): 710-715.
26. Papazafiropoulou A, Kardara M, Sotiropoulos A, Bousboulas S, Stamataki P, Pappas S. Plasma glucose levels and white blood cell count are related with ankle brachial index in type 2 diabetic subjects. Hellenic J Cardiol. 2010; 51(5): 402-406.
27. Muntner P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care. 2005; 28(8): 1981-1987.
28. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: glycated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004; 141(6): 421-431.
eISSN:1898-2263
ISSN:1232-1966